Single-Cell Multi-Omics Market - Global Forecast 2025-2032

The single-cell multi-omics market is at the forefront of life sciences innovation, rapidly reshaping how cellular diversity, diagnostics, and therapeutic discovery are approached across research and clinical sectors.

Market Snapshot: Single-Cell Multi-Omics Market Growth and Opportunity

The single-cell multi-omics market expanded from USD 3.18 billion in 2024 to USD 3.54 billion in 2025, maintaining a robust growth trajectory. With an anticipated CAGR of 11.27%, it is projected to reach USD 7.47 billion by 2032. This strong outlook reflects increasing adoption across precision diagnostics, high-resolution biological research, and targeted therapeutic development. The market's momentum is driven by advances in high-throughput analytical platforms, data integration technology, and the convergence of genomic, transcriptomic, proteomic, and spatial profiling workflows.

Scope & Segmentation

This report offers comprehensive coverage across the breadth of the single-cell multi-omics landscape, providing detailed analysis of critical industry segments and global regions:

• Product Categories: Consumables and reagents, including specialized kits and high-purity reagents; instruments such as flow cytometers, mass spectrometers, and sequencers; service offerings including bioinformatics data analysis, support, and maintenance.
• Technology Types: Genomic assays using scATAC-seq and scDNA-seq, proteomic profiling through label-free workflows and mass cytometry, transcriptomic methods like droplet- and plate-based platforms, and spatial multi-omics techniques such as imaging mass spectrometry and spatial transcriptomics.
• Applications: Biomarker discovery for diagnostics and prognostics, disease research in neurology and oncology, and drug discovery workflows including lead optimization and target identification.
• End Users: Academic and government research institutes, universities, hospital and independent clinical diagnostic laboratories, biotech firms, and large pharmaceutical companies.
• Workflows: Data analysis through AI and machine learning solutions, advanced bioinformatics, library preparation via barcoding and cDNA synthesis kits, and sample preparation methods such as cell isolation and cell sorting.
• Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East, and Africa (including United Kingdom, Germany, France, and others), and Asia-Pacific (including China, India, Japan, Australia, South Korea, and more).
• Company Analysis: Includes leading organizations such as 10x Genomics, Illumina, Bio-Rad Laboratories, Becton Dickinson, Standard BioTools, NanoString Technologies, Takara Bio, Mission Bio, IsoPlexis, and Resolve Biosciences.

Key Takeaways for Senior Decision-Makers

• Single-cell multi-omics is transforming traditional research paradigms by providing high-dimensional insights into gene expression, protein abundance, and cellular organization at unprecedented resolution.
• Integrated multi-modal platforms are becoming central to both discovery and translational research, enabling comprehensive cellular profiling that supports early disease detection and informed therapeutic development.
• Technological breakthroughs in microfluidics, mass spectrometry, and spatial transcriptomics are driving competitive differentiation and accelerating scientific discoveries across developmental biology, immunology, and oncology.
• Strategic partnerships among instrumentation suppliers, reagent providers, computational experts, and clinical organizations are fostering innovation and ensuring workflow interoperability.
• Regional adoption is influenced by factors such as local manufacturing capabilities, digital infrastructure, and the emergence of public-private initiatives that support broad access, especially in precision medicine applications.
• Effective data integration, advanced analytics, and customizable bioinformatics tools are essential requirements for organizations aiming to derive actionable insights and sustain market leadership in this evolving domain.

Tariff Impact: Navigating New Regulatory Challenges

The introduction of U.S. tariffs on imported instruments and consumables in 2025 has added complexity to market operations and procurement strategies. Organizations are increasingly sourcing locally manufactured reagents and embracing regional production hubs to counteract trade fluctuations. Companies are also adopting decentralized inventory strategies to maintain steady access to critical components, while closer supplier-end user collaborations are emerging to optimize cost efficiency and sustain research continuity despite regulatory uncertainties.

Methodology & Data Sources

This research utilizes a rigorous methodology blending primary insights from key academic and industry stakeholders with secondary data from peer-reviewed literature, patent filings, and company disclosures. Data triangulation and analytics tools ensure validated, accurate trend analysis, supported by case studies and expert panel reviews for comprehensive credibility.

Why This Report Matters

• Enables executive decision-makers to identify emerging opportunities across all product, technology, and application segments within the single-cell multi-omics market.
• Equips organizations with actionable strategic guidance for navigating evolving supply chains, regulatory trends, and regional dynamics.
• Provides a validated, in-depth intelligence framework for investment planning, competitive differentiation, and long-term growth strategies.

Conclusion

The single-cell multi-omics market offers dynamic, multi-faceted growth prospects as innovation, adaptability, and strategic collaboration drive industry evolution. This report delivers the essential clarity and strategic insights that senior leaders need for informed and future-ready decision-making.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.